Hengxin Life (Stock Code: 301501) will land on ChiNext board on March 19, 2025.

Hengxin Life is publicly offering 25.5 million shares, including 25.5 million IPO shares offered at 39.92 yuan per share and raising funds of 1.018 billion yuan. The post-public-offering share capital of Hengxin Life is 102 million shares in total. Hefei Hengxin Life Science and Technology Co., Ltd. principally engages in the research, development, production and sale of paper and plastic tableware. In 2023, its operating income reached 1.425 billion yuan with the net profit of 213.8638 million yuan.